2018. Secukinumab Sustains Individual Clinical Responses Over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S21. DOI:https://doi.org/10.25251/skin.2.supp.21.